<SEC-DOCUMENT>0001193125-21-013858.txt : 20210122
<SEC-HEADER>0001193125-21-013858.hdr.sgml : 20210122
<ACCEPTANCE-DATETIME>20210121205500
ACCESSION NUMBER:		0001193125-21-013858
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20210119
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210122
DATE AS OF CHANGE:		20210121

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Acadia Healthcare Company, Inc.
		CENTRAL INDEX KEY:			0001520697
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35331
		FILM NUMBER:		21543513

	BUSINESS ADDRESS:	
		STREET 1:		6100 TOWER CIRCLE
		STREET 2:		SUITE 1000
		CITY:			FRANKLIN
		STATE:			TN
		ZIP:			37067
		BUSINESS PHONE:		615-861-6000

	MAIL ADDRESS:	
		STREET 1:		6100 TOWER CIRCLE
		STREET 2:		SUITE 1000
		CITY:			FRANKLIN
		STATE:			TN
		ZIP:			37067
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d115514d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:achc="http://www.acadiahealthcare.com/20210119" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2021-01-19_to_2021-01-19">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2021-01-19_to_2021-01-19">0001520697</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="achc-20210119.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2021-01-19_to_2021-01-19"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-19</xbrli:startDate> <xbrli:endDate>2021-01-19</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2021-01-19_to_2021-01-19">8-K</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2021-01-19_to_2021-01-19" format="ixt:datemonthdayyearen">January 19, 2021</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2021-01-19_to_2021-01-19">Acadia Healthcare Company, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2021-01-19_to_2021-01-19" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2021-01-19_to_2021-01-19">001-35331</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2021-01-19_to_2021-01-19">45-2492228</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification Number)</p></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2021-01-19_to_2021-01-19">6100 Tower Circle</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2021-01-19_to_2021-01-19">Suite 1000</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2021-01-19_to_2021-01-19">Franklin</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2021-01-19_to_2021-01-19" format="ixt-sec:stateprovnameen">Tennessee</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2021-01-19_to_2021-01-19">37067</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2021-01-19_to_2021-01-19">(615)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2021-01-19_to_2021-01-19">861-6000</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2021-01-19_to_2021-01-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2021-01-19_to_2021-01-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2021-01-19_to_2021-01-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2021-01-19_to_2021-01-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2021-01-19_to_2021-01-19">Common Stock, $0.01 par value</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2021-01-19_to_2021-01-19">ACHC</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2021-01-19_to_2021-01-19" format="ixt-sec:exchnameen">NASDAQ Global Select Market</ix:nonNumeric></span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2021-01-19_to_2021-01-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.02.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On January&#160;19, 2021, Acadia Healthcare Company, Inc., a Delaware corporation (the &#8220;Company&#8221;), through its subsidiary Acadia Management Company, Inc., entered into a new employment agreement (the &#8220;<span style="text-decoration:underline">Agreement</span>&#8221;) with Ms.&#160;Debra K. Osteen, the Chief Executive Officer of the Company and a member of the Company&#8217;s board of directors (the &#8220;<span style="text-decoration:underline">Board</span>&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Agreement includes the following terms: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Annual Cash Compensation</span>. Ms.&#160;Osteen&#8217;s annual base salary will be $1,000,000 and her target annual bonus will be 100% of her base salary (up to a maximum cash bonus of 200% of her base salary). Ms.&#160;Osteen&#8217;s salary may be increased from time to time at the Board&#8217;s or compensation committee&#8217;s discretion. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Annual Equity Awards</span>. For 2021, Ms.&#160;Osteen will be entitled to a long-term incentive award consisting entirely of performance restricted stock units with a target value equal to $5.2&#160;million. The long-term incentive award will have a <span style="white-space:nowrap">one-year</span> performance period ending December&#160;31, 2021. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Termination Payments</span>. In the event that the Company terminates her employment without &#8220;cause&#8221; or if she resigns her employment for &#8220;good reason&#8221; (each as defined in the Agreement), Ms.&#160;Osteen will be entitled to receive the following severance benefits, subject to Ms.&#160;Osteen&#8217;s timely execution <span style="white-space:nowrap">and&#160;non-revocation&#160;of</span> a general release of claims in favor of the Company: (i)&#160;accrued, but unpaid base salary, paid time off and sick pay, (ii)&#160;accrued but unpaid cash bonus with respect to the completed performance period, (iii)&#160;continued payment of her base salary from the termination date through December&#160;31, 2021, as if Ms.&#160;Osteen had continued to be employed during such period, (iv)&#160;annual bonus for the year of termination based on actual performance, which amount shall not be prorated and paid as if Ms.&#160;Osteen had remained employed through December&#160;31, 2021, (v)&#160;Company payment of health insurance premiums for 18 months and (vi)&#160;with respect to the long term incentive award, to the extent that it shall not otherwise have become vested, (A)&#160;the service-based vesting requirement shall be deemed satisfied; and (B)&#160;the long term incentive award will remain outstanding and eligible to vest based on actual achievement of the applicable performance conditions. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Restrictive Covenants</span>. Ms.&#160;Osteen will be subject <span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap">to&#160;non-competition,&#160;non-solicitation&#160;and&#160;non-disparagement&#160;covenants,</span></span></span> during the term of her employment and for specified periods thereafter. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Agreement is qualified in its entirety by reference to the text of the Agreement, a copy of which is filed herewith as Exhibit 10.1, and is incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(d)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Exhibits </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit<br />No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d115514dex101.htm">Employment Agreement with Ms.&#160;Osteen dated January&#160;19, 2021. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data (embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="3" style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">ACADIA HEALTHCARE COMPANY, INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: January&#160;21, 2021</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher L. Howard</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Christopher L. Howard</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Executive Vice President, Secretary and General Counsel</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d115514dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EMPLOYMENT AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS EMPLOYMENT AGREEMENT (this &#147;<U>Agreement</U>&#148;) is made and entered into as of January&nbsp;19, 2021 by and between Acadia
Management Company, Inc., a Delaware corporation (the &#147;<U>Compan</U>y&#148;), and Debra K. Osteen (&#147;<U>Executive</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company and the Executive are a party to that certain Employment Agreement, dated as of December&nbsp;16, 2018 (the
&#147;Original Employment Agreement&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Original Employment Agreement expired on December&nbsp;31, 2020; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company and the Executive desire to enter into a new employment agreement as provided herein, effective as of the date hereof;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties hereto agree as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Employment; Employment Period</U>. The Company
shall continue to employ Executive, and Executive hereby accepts continued employment with the Company, upon the terms and conditions set forth in this Agreement for the period beginning as of January&nbsp;1, 2021 and ending on December&nbsp;31,
2021 (the &#147;<U>Employment Period</U>&#148;). Notwithstanding the foregoing, Executive&#146;s employment hereunder may be earlier terminated in accordance with (and subject to) <U>Section</U><U></U><U>&nbsp;4</U> hereof. The place of employment
of Executive shall be the principal executive offices and corporate headquarters of the Company and Acadia Healthcare Company, Inc., a Delaware corporation (&#147;<U>Acadia</U>&#148;), which, during the Employment Period, shall be located in
Williamson County, Tennessee. Executive will spend substantially all Executive&#146;s business time in the Williamson County, Tennessee corporate office (other than while traveling for business purposes). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Position and Duties</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Position; Responsibilities</U>. During the Employment Period, Executive shall serve as the Chief Executive Officer of Acadia, and shall
have the normal duties, responsibilities, functions and authority of a chief executive officer in similarly sized companies that are not inconsistent with Executive&#146;s position as Chief Executive Officer, subject to the power and authority of
the board of directors (the &#147;<U>Board</U>&#148;) of Acadia, to expand or limit such duties, responsibilities, functions and authority within the scope of duties, responsibilities, functions and authority associated with the position of Chief
Executive Officer and to overrule actions of officers of the Company. Acadia shall cause the nominating and corporate governance committee of the Board (the &#147;<U>Nominating Committee</U>&#148;) to nominate Executive to serve as a member of the
Board each year during the Employment Period that Executive&#146;s term of Board service is to be slated for reelection to the Board. If the Company&#146;s stockholders vote in favor of the Nominating Committee&#146;s nomination of Executive to
serve as a member of the Board, Executive agrees to serve in such capacity. During the Employment Period, Executive agrees to serve on all other boards of directors of Subsidiaries of the Company or its affiliates and Executive agrees that any such
board service shall be without additional compensation. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Reportin</U>g<U>; Performance of Duties</U>. Executive shall report to the Board and
all employees of Acadia and its Subsidiaries shall report to Executive or her designee(s). Executive shall devote substantially all of her business time and attention (except for permitted vacation periods and reasonable periods of illness or other
incapacity) to the business and affairs of Acadia and the Subsidiaries. So long as Executive is employed by the Company, Executive shall not, without the prior written consent or approval of the Board, perform other services for compensation.
Notwithstanding the foregoing, nothing herein shall preclude Executive from (i)&nbsp;serving, with the prior written consent of the Board, as a member of the boards of directors or advisory boards (or their equivalents in the case of a <FONT
STYLE="white-space:nowrap">non-corporate</FONT> entity) of <FONT STYLE="white-space:nowrap">for-profit</FONT> companies or businesses which are not directly competitive with the Company or any Subsidiary (provided that the prior written consent of
the Board shall not be required for Executive to serve as a member of the boards of directors or advisory boards (or their equivalents) of the companies listed on <U>Exhibit A</U>, (ii)&nbsp;engaging in charitable activities and community affairs
(including serving as a member of the boards of directors or advisory boards (or their equivalents in the case of a <FONT STYLE="white-space:nowrap">non-corporate</FONT> entity) of
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">not-for-profit,</FONT></FONT> charitable or community organizations which are not directly competitive with the Company or any Subsidiary); and (iii)&nbsp;managing Executive&#146;s
personal and legal affairs and her passive personal investments; provided, however, the activities set out in clauses (i)&nbsp;and (ii) above shall be limited by Executive so as not to materially interfere, individually or in the aggregate, with the
performance of her duties and responsibilities hereunder. For the avoidance of doubt, so long as Executive is employed by the Company, Executive shall not provide any services to any company or business that is directly competitive with Acadia or
the Subsidiaries (whether <FONT STYLE="white-space:nowrap">for-profit</FONT> or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">not-for-profit)</FONT></FONT> without the prior written consent of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Compensation and Benefits</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Base Salar</U>y. During the Employment Period, Executive&#146;s base salary shall be $1,000,000 per annum, subject to increase by the
Board or Acadia&#146;s Compensation Committee (the &#147;<U>Compensation Committee</U>&#148;) (as increased from time to time, the &#147;<U>Base Salar</U>y&#148;), which salary shall be payable by the Company in regular installments in accordance
with the Company&#146;s general payroll practices (as in effect from time to time). The Base Salary for any partial year during the Employment Period will be based upon the actual number of days elapsed in such year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Business Expenses</U>. During the Employment Period, the Company shall reimburse Executive in the calendar year in which they are
incurred for all reasonable <FONT STYLE="white-space:nowrap">out-of-pocket</FONT> business expenses incurred by her in the course of performing her duties and responsibilities under this Agreement which are consistent with the Company&#146;s
policies in effect from time to time with respect to travel, entertainment and other business expenses, subject to the Company&#146;s requirements with respect to reporting and documentation of such expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Bonus</U>. In addition to the Base Salary, during the calendar year ending December&nbsp;31, 2021, Executive will be eligible to earn a
target annual cash bonus of 100% of Executive&#146;s Base Salary (the &#147;<U>Target Bonus</U>&#148;), with a range of 0% for performance below threshold performance, 50% of Base Salary at threshold performance, up to a maximum cash bonus
determined in accordance with the Company&#146;s annual bonus plan for senior executives (which for Executive shall be 200% of Base Salary), if and only if Executive, Acadia and the Subsidiaries achieve the performance criteria specified by the
Board or the Compensation Committee for such year, as determined by the Board or the Compensation Committee in its sole </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
discretion. The performance criteria for any particular year shall be set by the Board or the Compensation Committee no later than ninety (90)&nbsp;days after the commencement of the relevant
year, with 75% of such performance criteria to be based on financial goals that are consistent with other members of the senior management team and 25% to be based on qualitative, quantitative and other objectives known as the &#147;Board
Objectives&#148;, in each case, established by the Board or the Compensation Committee after consultation with Executive. Unless otherwise agreed to by Executive, any such bonus amount for any year shall be earned (if awarded) on the last day of
such year and paid by the Company in the calendar year following the calendar year to which such bonus has been earned and no later than the earlier of (x)&nbsp;the date that is ten (10)&nbsp;business days after the Company&#146;s receipt of its
audited financial statements for the calendar year with respect to which such bonus has been earned and (y)&nbsp;December&nbsp;31 of the calendar year following such year with respect to which such bonus has been earned, regardless of whether
Executive continues to be employed by the Company as of such payment date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Lon</U>g<U>-Term Incentive Compensation</U>. Executive
will be entitled to a long-term incentive award in 2021 consisting entirely of performance restricted stock units (the &#147;<U>2021 Award</U>&#148;) that will have a target value equal to $5.2&nbsp;million (such value to be determined on the same
basis as the Compensation Committee values such awards generally). The 2021 Award will have a <FONT STYLE="white-space:nowrap">one-year</FONT> performance period ending December&nbsp;31, 2021, with the following percentages of the target number of
shares vesting based on Executive&#146;s continued employment until the end of the performance period and the applicable level of achievement against the performance goals: (i) 0%&#151;less than threshold performance; (ii) 50%&#151;threshold
performance; (iii) 100%&#151;target performance; and (iv) 200%&#151;maximum performance. The applicable performance criteria will be established by the Board or the Compensation Committee, with 75% of such performance criteria to be based on
financial goals that are consistent with other members of the senior management team and 25% to be based on the Board Objectives, in each case, established by the Board or the Compensation Committee after consultation with Executive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Benefits</U>. In addition to (but without duplication of) the Base Salary and any bonuses payable to Executive pursuant to this
<U>Section</U><U></U><U>&nbsp;3</U>, Executive shall be entitled to participate at her sole discretion in all of the Company&#146;s employee benefit programs for which senior executive employees of the Company are generally eligible. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Counsel Fees</U>. Upon presentation of appropriate documentation, the Company shall pay Executive&#146;s reasonable counsel fees
incurred in connection with the negotiation and documentation of this Agreement in an amount up to $35,000, and matters related hereto, payable within thirty (30)&nbsp;days following the execution of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Termination</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
<U>Termination</U>. The Employment Period shall terminate automatically and immediately upon Executive&#146;s resignation for any reason (whether with Good Reason or without Good Reason), Executive&#146;s death or becoming Disabled, or upon the
termination of Executive&#146;s employment by the Company (through action by the Board) for any reason (whether for Cause or without Cause). The date on which Executive ceases to be employed by the Company is referred to herein as the
&#147;<U>Termination Date</U>.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Termination without Cause or with Good Reason</U>. If Executive&#146;s employment is
terminated by the Company without Cause or by Executive with Good Reason, then Executive shall be entitled to receive: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)
Executive&#146;s unpaid Base Salary through the Termination Date (payable in accordance with <U>Section</U><U></U><U>&nbsp;3(a)</U>) and any accrued but unpaid cash bonus with respect to a completed performance period; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) payment in respect of any unused paid time off and sick pay of Executive in such amounts as have accrued as of the
Termination Date in accordance with the Company&#146;s policies with respect thereto as in effect during the Employment Period, and reimbursement of any business expenses incurred by Executive but not reimbursed prior to the Termination Date in
accordance with and reimbursable under the terms of the Company&#146;s policies with respect thereto as in effect on the Termination Date (in each case, payable in a lump sum within ten (10)&nbsp;business days after the Termination Date) and all
other payments, benefits or fringe benefits to which Executive shall be entitled under the terms of any applicable compensation arrangement or benefit, equity or fringe benefit plan or program or grant or this Agreement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) continued payment of the Executive&#146;s Base Salary, payable in accordance with the Company&#146;s general payroll
practices (as in effect from time to time) from the Termination Date through December&nbsp;31, 2021, as if Executive had continued to be employed during such period; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) an amount equal to the actual annual cash bonus amount to which Executive would be entitled under
<U>Section</U><U></U><U>&nbsp;3(c)</U> with respect to the 2021 calendar year, determined based on achievement of the performance objectives specified in Executive&#146;s bonus plan for such year (with any subjective performance criteria other than
the Board Objectives deemed achieved at target and the achievement of the Board Objectives to be determined in good faith by the Board based on Executive&#146;s achievement against the Board Objectives in a manner consistent with how achievement is
measured for other executive officers of the Company), as determined by the Board or the Compensation Committee consistent with other senior executives of the Company, which amount shall not be prorated and paid as if Executive had remained employed
through December&nbsp;31, 2021 (payable at the same time it would have been paid pursuant to <U>Section</U><U></U><U>&nbsp;3(c)</U>); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) an amount equal to the <FONT STYLE="white-space:nowrap">after-tax</FONT> cost of the premiums for continued health and
dental insurance for Executive and/or Executive&#146;s dependents in accordance with the Consolidated Budget Reconciliation Act of 1985 (&#147;<U>COBRA</U>&#148;) for the period commencing on the Termination Date and ending on the eighteen-month
anniversary of the Termination Date (payable in monthly installments during and concurrently with Executive&#146;s COBRA period; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) with respect to the 2021 Award, to the extent that it shall not
otherwise have become vested, (A)&nbsp;the service-based vesting requirement shall be deemed satisfied; and (B)&nbsp;the 2021 Award will remain outstanding and eligible to vest based on actual achievement of the applicable performance conditions
(with any subjective performance criteria other than the Board Objectives deemed achieved at target and the achievement of the Board Objectives to be determined in good faith by the Board based on Executive&#146;s achievement against the Board
Objectives in a manner consistent with how achievement is measured for other executive officers). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, Executive shall be
entitled to receive such payments described in <U>Section</U><U></U><U>&nbsp;4(b)(iii)</U> through 4(b)(vi) only so long as Executive has not breached any of the provisions of <U>Sections 5</U>, <U>6</U> and <U>7</U> hereof, and all amounts payable
and benefits or additional rights provided pursuant to <U>Section</U><U></U><U>&nbsp;4(b)(iii)</U> through 4(b)(vi) shall only be payable if Executive delivers to the Company and does not revoke a general release of claims in favor of the Company in
substantially the form attached on <U>Exhibit B</U> hereto; such release shall be executed and delivered (and no longer subject to revocation, if applicable) within sixty (60)&nbsp;days following Executive&#146;s termination (the &#147;<U>Release
Requirement</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Termination by Death or Disabilit</U>y. If Executive&#146;s employment is terminated due to
Executive&#146;s death or becoming Disabled, then Executive (or her estate or beneficiary) shall be entitled to receive: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Executive&#146;s unpaid Base Salary through the Termination Date (payable in accordance with
<U>Section</U><U></U><U>&nbsp;3(a)</U>) and any accrued but unpaid cash bonus with respect to a completed performance period; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) payment in respect of any unused paid time off and sick pay of Executive in such amounts as have accrued as of the
Termination Date in accordance with the Company&#146;s policies with respect thereto as in effect during the Employment Period, and reimbursement of any business expenses incurred by Executive but not reimbursed prior to the Termination Date in
accordance with and reimbursable under the terms of the Company&#146;s policies with respect thereto as in effect on the Termination Date (in each case, payable in a lump sum within ten (10)&nbsp;business days after the Termination Date) and all
other payments, benefits or fringe benefits to which Executive shall be entitled under the terms of any applicable compensation arrangement or benefit, equity or fringe benefit plan or program or grant or this Agreement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) an amount equal to the actual annual cash bonus amount to which Executive would be entitled under
<U>Section</U><U></U><U>&nbsp;3(c)</U> with respect to the calendar year in which the Termination Date occurs, determined based on achievement of the performance objectives specified in Executive&#146;s bonus plan for such year (with any subjective
performance criteria deemed achieved at target), as determined by the Board or the Compensation Committee consistent with other senior executives of the Company, which amount shall be prorated based on the actual number of days elapsed in such year
prior to the Termination Date (payable at the same time it would have been paid pursuant to <U>Section</U><U></U><U>&nbsp;3(c)</U>); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) an amount equal to the
<FONT STYLE="white-space:nowrap">after-tax</FONT> cost of the premiums for continued health and dental insurance for Executive and/or Executive&#146;s dependents in accordance with COBRA for the period commencing on the Termination Date and ending
on the earliest of (A)&nbsp;the date on which Executive&#146;s COBRA period terminates or expires, (B)&nbsp;six (6) months after the Termination Date, and (C)&nbsp;the date on which Executive becomes eligible for long-term disability benefits under
any long-term disability program sponsored by the Company (payable in monthly installments during and concurrently with Executive&#146;s COBRA period); provided that if Executive&#146;s COBRA period is terminated prior to expiration of the period
commencing on the Termination Date and ending on the earlier of (I)&nbsp;the date on which Executive becomes eligible for long-term disability benefits under any long-term disability program sponsored by the Company, and (II)&nbsp;six (6) months
after the Termination Date (such period, the &#147;<U>Disability Severance Period</U>&#148;), then Executive shall be entitled to continue to receive an amount equal to the cost of the premiums for continued health and dental insurance for Executive
and/or Executive&#146;s dependents in accordance with COBRA (assuming such continued insurance coverage remained available at the same monthly cost) payable in monthly installments during the period commencing on the date of such termination or
expiration and ending on the date on which the Disability Severance Period expires; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) with respect to the 2021
Award, to the extent that it shall not otherwise have become vested, (A)&nbsp;the service-based vesting requirement shall be deemed satisfied; and (B)&nbsp;the 2021 Award will remain outstanding and eligible to vest based on actual achievement of
the applicable performance conditions (with subjective performance criteria deemed to be achieved at target). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, if Executive&#146;s employment
is terminated due to Executive&#146;s becoming Disabled (but, for the avoidance of doubt, not due to her death), then Executive (or her estate or beneficiary) shall be entitled to receive, during the Disability Severance Period, continued
installment payments of Executive&#146;s Base Salary as in effect on the Termination Date, which shall be payable over the Disability Severance Period in regular installments in accordance with the Company&#146;s general payroll practices as in
effect on the Termination Date, but in no event less frequently than monthly. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Other Termination</U>. If Executive&#146;s
employment is terminated (i)&nbsp;by the Company for Cause, or (ii)&nbsp;by Executive&#146;s resignation without Good Reason, then the Company shall pay Executive (A)&nbsp;Executive&#146;s unpaid Base Salary through the Termination Date (payable in
accordance with <U>Section</U><U></U><U>&nbsp;3(a)</U>) and (B)&nbsp;any bonus amount under <U>Section</U><U></U><U>&nbsp;3(c)</U> to which Executive is entitled determined by reference to the calendar year that ended on or prior to the Termination
Date (payable at the same time it would have been paid pursuant to <U>Section</U><U></U><U>&nbsp;3(c)</U>) and all other payments, benefits or fringe benefits to which Executive shall be entitled under the terms of any applicable compensation
arrangement or benefit, equity or fringe benefit plan or program or grant or this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Treatment of 2019 and 2020 Equity Awards</U>. If Executive&#146;s employment with the
Company terminates for any reason other than a termination by the Company for Cause, annual equity and equity-based awards granted to Executive in 2019 and 2020 (the &#147;<U>2019 and 2020 </U><U>Awards</U>&#148;) shall be treated as set forth
below, subject to Executive&#146;s satisfaction of the Release Requirement: (i)&nbsp;the time or service vesting component(s) of the 2019 and 2020 Awards will be deemed satisfied upon such termination of employment; and (ii) 2019 and 2020 Awards
subject to performance-based vesting will remain outstanding and eligible to vest based on actual achievement of the applicable performance conditions, subject to the terms and conditions set forth in the applicable award agreement and/or governing
documentation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Continuation of Benefits</U>. Upon any termination of employment, whether voluntary or otherwise, Executive shall
have the option to elect health insurance coverage for herself, her spouse and her eligible dependents during the period commencing on the end of the statutory COBRA period, if any (provided that Executive validly elected COBRA continuation
coverage), until the earlier of the date on which Executive (A)&nbsp;is eligible to participate in another health benefit plan (including, without limitation, a plan sponsored by a then current or former employer of Executive&#146;s or
Executive&#146;s spouse, other than a plan that provides for &#147;excepted benefits&#148; as defined under section 733(c) of the Employee Retirement Income Security Act of 1974) or (B)&nbsp;becomes eligible for Medicare. Such coverage will be
provided for by the Company (or any successor to the Company, whether by operation of law or otherwise) in accordance with applicable law, and Executive shall pay premiums consistent with other senior executive employees of the Company (or any
successor to the Company, whether by operation of law or otherwise). Executive agrees to take all required actions and provide any requested personal medical history and information, in accordance with the applicable policy application and medical
underwriting process. Nothing in this <U>Section</U><U></U><U>&nbsp;4(g)</U> shall decrease or reduce Executive&#146;s rights or entitlements under <U>Sections</U><U></U><U>&nbsp;4(b)(v)</U> or <U>4(c)(v)</U> hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>No Miti</U>g<U>ation</U>. Executive is under no obligation to mitigate damages or the amount of any payment provided for under this
<U>Section</U><U></U><U>&nbsp;4</U> by seeking other employment or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Right of Offset</U>. The Company may offset any bona
fide obligations that Executive owes Acadia or any of the Subsidiaries (which for the avoidance of doubt shall not include any unliquidated obligations or obligations to the extent Executive disputes in good faith the nature or amount thereof)
against any amounts the Company or any of the Subsidiaries owes Executive hereunder; provided that, notwithstanding the foregoing or any other provision of this Agreement to the contrary, in no event shall any payment under this Agreement that
constitutes &#147;deferred compensation&#148; for purposes of Code Section&nbsp;409A be subject to offset, counterclaim or recoupment by any other amount unless otherwise permitted by Code Section&nbsp;409A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Section 409A Compliance</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) The intent of the parties is that payments and benefits under this Agreement comply with Internal Revenue Code
Section&nbsp;409A and the regulations and guidance promulgated thereunder (collectively &#147;<U>Code Section</U><U></U><U>&nbsp;409A</U>&#148;) and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in
compliance therewith. In no event whatsoever shall Acadia or any of the Subsidiaries be liable for any additional tax, interest or penalty that may be imposed on Executive by Code Section&nbsp;409A or damages for failing to comply with Code
Section&nbsp;409A. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) A termination of employment shall not be deemed to have occurred for
purposes of any provision of this Agreement providing for the payment of any amounts or benefits upon or following a termination of employment unless such termination is also a &#147;separation from service&#148; within the meaning of Code
Section&nbsp;409A and, for purposes of any such provision of this Agreement, references to a &#147;termination,&#148; &#147;termination of employment,&#148; &#147;termination of the Employment Period&#148; or like terms shall mean &#147;separation
from service.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) All expenses or other reimbursements under this Agreement shall be made on or prior to the last
day of the taxable year following the taxable year in which such expenses were incurred by Executive (provided that if any such reimbursements constitute taxable income to Executive, such reimbursements shall be paid no later than March 15th of the
calendar year following the calendar year in which the expenses to be reimbursed were incurred), and no such reimbursement or expenses eligible for reimbursement in any taxable year shall in any way affect the expenses eligible for reimbursement in
any other taxable year. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) For purposes of Code Section&nbsp;409A, Executive&#146;s right to receive any installment
payment pursuant to this Agreement shall be treated as a right to receive a series of separate and distinct payments. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v)
Whenever a payment under this Agreement specifies a payment period with reference to a number of days (e.g., &#147;payment shall be made within fifteen (15)&nbsp;days following the Termination Date&#148;), the actual date of payment within the
specified period shall be within the sole discretion of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) Notwithstanding any other payment schedule
provided herein to the contrary, if Executive is deemed on the Termination Date to be a &#147;specified employee&#148; within the meaning of that term under Code Section&nbsp;409A(a)(2)(B), then any payment that is considered deferred compensation
under Code Section&nbsp;409A payable on account of a &#147;separation from service&#148; shall be made on the date which is the earlier of (i)&nbsp;the expiration of the six (6)-month period measured from the date of such &#147;separation from
service&#148; of Executive and (ii)&nbsp;the date of Executive&#146;s death (the &#147;<U>Delay Period</U>&#148;) to the extent required under Code Section&nbsp;409A. Upon the expiration of the Delay Period, all payments delayed pursuant to the
immediately preceding sentence (whether they otherwise would have been payable in a single sum or in installments in the absence of such delay) shall be paid to Executive in a lump sum, and all remaining payments due under this Agreement shall be
paid or provided in accordance with the normal payment dates specified for them herein. In addition, if Executive is a &#147;specified employee,&#148; to the extent that welfare benefits to be provided to Executive pursuant to this Agreement are not
&#147;disability pay,&#148; &#147;death benefit&#148; plans or <FONT STYLE="white-space:nowrap">non-taxable</FONT> medical benefits within the meaning of Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(a)(5)</FONT> or
other benefits not considered nonqualified deferred compensation within the meaning of that regulation, such provision of benefits shall be delayed until the end of the Delay Period. Notwithstanding the foregoing, to the extent that the previous
sentence applies to the provision of any ongoing health or welfare benefits that would not be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
required to be delayed if the premiums were paid by Executive, Executive shall pay the full cost of the premiums for such benefits during the Delay Period and the Company shall pay Executive an
amount equal to the amount of such premiums paid by Executive during the Delay Period within ten (10)&nbsp;days after the end of Delay Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Upon any termination of Executive&#146;s employment with the Company, Executive shall promptly resign, and shall be automatically deemed
to have resigned without the requirement of any further action, from any position as an officer, director or fiduciary of Acadia and the Company and their respective Affiliates (including, without limitation the Board of Acadia). Executive agrees to
execute any additional documentation reasonably requested by the Company to implement any such resignation contemplated herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.
<U>Confidential Information</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Protection of Confidential Information</U>. Executive acknowledges that the continued success of
Acadia and the Subsidiaries depends upon the use and protection of a large body of confidential and proprietary information. All of such confidential and proprietary information now existing or to be developed in the future will be referred to in
this Agreement as &#147;<U>Confidential Information</U>.&#148; Confidential Information will be interpreted broadly to include, without limitation, all information that is (i)&nbsp;related to Acadia&#146;s or the Subsidiaries&#146; (including any of
their predecessors&#146; prior to being acquired by the Company) current or potential business and (ii)&nbsp;is not generally or publicly known (including, without specific limitation, the information, observations and data concerning
(A)&nbsp;acquisition opportunities in or reasonably related to Acadia&#146;s or the Subsidiaries&#146; business or industry, (B)&nbsp;identities and requirements of, contractual arrangements with and other information regarding Acadia&#146;s or the
Subsidiaries&#146; employees (including personnel files and other information), suppliers, distributors, customers, independent contractors, third-party payors, providers or other business relations and their confidential information, including,
without limitation, patient records, medical histories and other information concerning patients (including, without limitation, all &#147;Protected Health Information&#148; within the meaning of the Health Insurance Portability and Accountability
Act), and (C)&nbsp;internal business information and intellectual property of every kind and description of Acadia and the Subsidiaries). Executive agrees that during the Employment Period and for five (5)&nbsp;years thereafter, she shall not
disclose to any unauthorized person or use for her own account any of such Confidential Information, whether or not developed by Executive, without the Board&#146;s prior written consent, unless and to the extent that any Confidential Information
(i)&nbsp;was known to Executive prior to the negotiation of this Agreement or the Employment Period from a source (other than Acadia, the Subsidiaries or any of their respective agents) that, to the knowledge of Executive, was not prohibited from
disclosing such information by a legal, contractual or fiduciary obligation to Acadia or any of the Subsidiaries, (ii)&nbsp;becomes generally known to and available for use by the public other than as a result of Executive&#146;s acts or omissions
to act or (iii)&nbsp;is required to be disclosed pursuant to any applicable law or court order. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Use of Others</U><U>&#146;</U><U>
Confidential Information</U>. During the Employment Period, Executive shall not use or disclose any confidential information or trade secrets, if any, of any former employers or any other Person to whom Executive has an obligation of
confidentiality. If at any time during her employment with the Company, Executive believes she is being asked to engage in work that will, or will be likely to, jeopardize any confidentiality or other obligations Executive may have to former
employers, then Executive shall immediately advise the Board so that Executive&#146;s duties can be modified appropriately. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Third-Party Information</U>. Executive understands that Acadia and the Subsidiaries
will receive from third parties confidential or proprietary information (&#147;<U>Third-Party Information</U>&#148;) subject to a duty on Acadia&#146;s and the Subsidiaries&#146; part to maintain the confidentiality of such information and to use it
only for certain limited purposes. During the Employment Period and thereafter, and without in any way limiting the provisions of <U>Section</U><U></U><U>&nbsp;5(a)</U> above, Executive will hold Third-Party Information in the strictest confidence
and will not disclose to anyone (other than personnel of Acadia or the Subsidiaries who need to know such information in connection with their work for Acadia or the Subsidiaries) or use, except in connection with her work for Acadia or the
Subsidiaries, Third-Party Information unless expressly authorized by the Board in writing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Whistleblower Protection</U>.
Notwithstanding anything to the contrary contained herein, no provision of this Agreement shall be interpreted so as to impede Executive (or any other individual) from reporting possible violations of federal law or regulation to any governmental
agency or entity, including but not limited to the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General, or making other disclosures under the whistleblower provisions of federal law or
regulation. Executive does not need the prior authorization of Acadia or any of the Subsidiaries to make any such reports or disclosures and Executive shall not be not required to notify the Acadia or any of the Subsidiaries that such reports or
disclosures have been made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Trade Secrets</U>. 18 U.S.C. &#167; 1833(b) provides: &#147;An individual shall not be held criminally
or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (A)&nbsp;is made (i)&nbsp;in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and
(ii)&nbsp;solely for the purpose of reporting or investigating a suspected violation of law; or (B)&nbsp;is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.&#148; Nothing in this
Agreement is intended to conflict with 18 U.S.C. &#167; 1833(b) or create liability for disclosures of trade secrets that are expressly allowed by 18 U.S.C. &#167; 1833(b). Accordingly, the parties to this Agreement have the right to disclose in
confidence trade secrets to federal, state, and local government officials, or to an attorney, for the sole purpose of reporting or investigating a suspected violation of law. The parties also have the right to disclose trade secrets in a document
filed in a lawsuit or other proceeding, but only if the filing is made under seal and protected from public disclosure. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Ownership
of Intellectual Property, Inventions and Patents</U>. Executive acknowledges that all discoveries, concepts, ideas, inventions, innovations, improvements, developments, methods, processes, programs, designs, analyses, drawings, reports, patent
applications, copyrightable work and mask work (whether or not including any confidential information) and all registrations or applications related thereto, all other proprietary information and all similar or related information (whether or not
patentable) which relate to Acadia&#146;s or the Subsidiaries&#146; actual or anticipated business, research and development or existing or future products or services and which are conceived, developed, contributed to, made or reduced to practice
by Executive (whether alone or jointly with others) while employed by Acadia or the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Subsidiaries after the date of this Agreement, including any of the foregoing that constitutes any proprietary information or records (&#147;<U>Work Product</U>&#148;), belong to Acadia or such
Subsidiary. Any copyrightable work prepared in whole or in part by Executive in the course of her work for any of the foregoing entities shall be deemed a &#147;work made for hire&#148; to the maximum extent permitted under copyright laws, and
Acadia or such Subsidiary shall own all rights therein. To the extent any such copyrightable work is not a &#147;work made for hire,&#148; Executive hereby assigns and agrees to assign to Acadia or such Subsidiary all right, title and interest,
including, without limitation, copyright, in and to such copyrightable work. Executive shall promptly disclose such Work Product to the Board and, at the Company&#146;s expense, perform all actions reasonably requested by the Board (whether during
or after the Employment Period) to establish and confirm such ownership by Acadia or such Subsidiary (including, without limitation, execution and delivery of assignments, consents, powers of attorney and other instruments). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U><FONT STYLE="white-space:nowrap">Non-Compete;</FONT> <FONT STYLE="white-space:nowrap">Non-Solicit</FONT></U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U><FONT STYLE="white-space:nowrap">Non-Compete</FONT></U>. In further consideration of the compensation to be paid to Executive
hereunder, Executive acknowledges that during the course of her employment with the Company she has and shall become familiar with Acadia&#146;s and the Subsidiaries&#146; trade secrets and with other Confidential Information concerning Acadia and
the Subsidiaries and that her services have been and shall be of special, unique and extraordinary value to Acadia and the Subsidiaries, and, therefore, Executive agrees that, during the Employment Period and for a period thereafter of twenty-four
(24)&nbsp;months (the &#147;<U>Noncompete Period</U>&#148;), she shall not (i)&nbsp;directly or indirectly own any interest in, manage, control, participate in, consult with, render services for, or in any manner engage in any business that derives
at least 25% of its gross revenue from (A)&nbsp;the business of providing behavioral healthcare and/or related services, or (B)&nbsp;any other material business in which Acadia or any of its Subsidiaries planned to be engaged in on or after such
date of which the Executive has or should have had actual knowledge, or (ii)&nbsp;directly or indirectly manage, control, participate in, consult with or render services specifically with respect to any unit, division, segment or subsidiary of any
other business that engages in or otherwise competes with (or was organized for the purpose of engaging in or competing with) the business of providing behavioral healthcare and/or related services (provided that, this clause (ii)&nbsp;shall not be
construed to prohibit Executive from directly or indirectly owning any interest in, managing, controlling, participating in, consulting with, rendering services for, or in any manner engaging in any business activities with or for such business
generally and, for the avoidance of doubt, not specifically with respect to such unit, division, segment or subsidiary), in each case, within any geographical area in which Acadia and the Subsidiaries engage in such businesses; provided that
Executive shall not be subject to the restrictions set forth in this <U>Section</U><U></U><U>&nbsp;7(a)</U> if the Employment Period is terminated by the Company without Cause or by Executive with Good Reason and for so long as the Company is in
breach of its obligations under <U>Section</U><U></U><U>&nbsp;4(b)</U> and such breach is not the subject of a good faith dispute between the Company and Executive. For purposes of this Agreement, the term &#147;participate in&#148; shall include,
without limitation, having any direct or indirect interest in any Person, whether as a sole proprietor, owner, stockholder, partner, joint venturer, creditor or otherwise, or rendering any direct or indirect service or assistance to any individual,
corporation, partnership, joint venture and other business entity (whether as a director, officer, manager, supervisor, employee, agent, consultant or otherwise). Nothing herein shall prohibit Executive from being a passive owner of not more than 2%
of the outstanding stock of any class of a corporation which is publicly traded, so long as Executive has no active participation in the business of such corporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U><FONT STYLE="white-space:nowrap">Non-Solicit</FONT></U>. During the Employment Period
and for a period thereafter of twenty-four (24)&nbsp;months (the &#147;<U>Nonsolicit Period</U>&#148;), Executive shall not directly or indirectly through another Person (other than on behalf of Acadia and the Subsidiaries)&nbsp;(i) induce or
attempt to induce any employee or independent contractor of Acadia or the Subsidiaries to leave the employ or services of Acadia or the Subsidiaries, or in any way willfully interfere with the relationship between Acadia and the Subsidiaries and any
employee or independent contractor thereof, (ii)&nbsp;hire or seek any business affiliation with any person who was an employee or independent contractor of Acadia or the Subsidiaries at any time during the twelve (12)&nbsp;months prior to the
Termination Date or (iii)&nbsp;willfully induce or attempt to induce any customer, supplier, licensee, licensor or other business relation of Acadia or any Subsidiary to cease doing business with Acadia or such Subsidiary or willfully interfere with
the relationship between any such customer, supplier, licensor or other business relation and Acadia or any Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U><FONT
STYLE="white-space:nowrap">Non-Dispara</FONT></U>g<U>ement</U>. Without limiting any other obligation of Executive pursuant to this Agreement, Executive hereby covenants and agrees that, except as may be required by applicable law, Executive shall
not make any statement, written or verbal, in any forum or media, or take any other action in disparagement of Acadia or any of its Subsidiaries, during the Employment Period and for a period of five (5)&nbsp;years thereafter (the &#147;<U><FONT
STYLE="white-space:nowrap">Non-Disparagement</FONT> Period</U>&#148;). Without limiting any other obligation of Acadia and its Subsidiaries pursuant to this Agreement, Acadia hereby covenants and agrees that, except as may be required by applicable
law, Acadia shall direct its executive officers and members of its board of directors (and use commercially reasonable efforts to obtain compliance with such direction) not to make any statement, written or verbal, in any forum or media, or take any
other action in disparagement of Executive, during the Employment Period and the <FONT STYLE="white-space:nowrap">Non-Disparagement</FONT> Period. This Section&nbsp;7(c) will not be violated by (i)&nbsp;truthful statements required to be made by law
or legal process, or (ii)&nbsp;internal statements in connection with providing services to Acadia and its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)
<U>Blue-Pencil</U>. If, at the time of enforcement of <U>Section</U><U></U><U>&nbsp;5</U> or <U>6</U> or this <U>Section</U><U></U><U>&nbsp;7</U>, a court shall hold that the duration, scope or area restrictions stated herein are unreasonable under
circumstances then existing, the parties agree that the maximum duration, scope or area reasonable under such circumstances shall be substituted for the stated duration, scope or area and that the court shall be allowed to revise the restrictions
contained herein to cover the maximum duration, scope and area permitted by law. Executive hereby acknowledges and represents that she has either consulted with independent legal counsel regarding her rights and obligations under this Agreement or
knowingly and voluntarily waived the opportunity to do so and that she fully understands the terms and conditions contained herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)
<U>Additional Acknowled</U>g<U>ments</U>. Executive acknowledges that the provisions of <U>Sections 5</U> and <U>6</U> and this <U>Section</U><U></U><U>&nbsp;7</U> are in consideration of Executive&#146;s employment with the Company and other good
and valuable consideration as set forth in this Agreement. In addition, Executive agrees and acknowledges that the restrictions contained in <U>Sections 5</U> and <U>6</U> and this <U>Section</U><U></U><U>&nbsp;7</U> do not preclude Executive from
earning a livelihood, nor do they unreasonably impose limitations on Executive&#146;s ability to earn a living. In addition, Executive acknowledges (x)&nbsp;that the business of Acadia and the Subsidiaries will be conducted throughout the United
States and its </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
territories and beyond, (y)&nbsp;notwithstanding the state of organization or principal office of Acadia or any of the Subsidiaries or facilities, or any of their respective executives or
employees (including Executive), it is expected that Acadia and the Subsidiaries will have business activities and have valuable business relationships within its industry throughout the United States and its territories and beyond, and (z)&nbsp;as
part of Executive&#146;s responsibilities, Executive will be traveling throughout the United States and other jurisdictions where Acadia and the Subsidiaries conduct business during the Employment Period in furtherance of the Company&#146;s business
relationships. Executive agrees and acknowledges that the potential harm to Acadia and the Subsidiaries of the <FONT STYLE="white-space:nowrap">non-enforcement</FONT> of any provision of <U>Sections 5</U> and <U>6</U> and this
<U>Section</U><U></U><U>&nbsp;7</U> outweighs any potential harm to Executive of its enforcement by injunction or otherwise. Executive acknowledges that she has carefully read this Agreement and either consulted with legal counsel of
Executive&#146;s choosing regarding its contents or knowingly and voluntarily waived the opportunity to do so, has given careful consideration to the restraints imposed upon Executive by this Agreement and is in full accord as to their necessity for
the reasonable and proper protection of confidential and proprietary information of Acadia and the Subsidiaries now existing or to be developed in the future. Executive expressly acknowledges and agrees that each and every restraint imposed by this
Agreement is reasonable with respect to subject matter, duration and geographical area. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Specific Performance</U>. In the event of
the breach or a threatened breach by Executive of any of the provisions of <U>Section</U><U></U><U>&nbsp;5</U> or <U>6</U> or this <U>Section</U><U></U><U>&nbsp;7</U>, Acadia and the Subsidiaries would suffer irreparable harm and that money damages
would not be a sufficient remedy and, in addition and supplementary to other rights and remedies existing in its favor whether under this Agreement or under any other agreement, the Company shall be entitled to specific performance and/or injunctive
or other equitable relief from a court of competent jurisdiction in order to enforce or prevent any violations of the provisions hereof (without posting a bond or other security). In addition, in the event of an alleged breach or violation by
Executive of this <U>Section</U><U></U><U>&nbsp;7</U>, the Noncompete Period or the Nonsolicit Period, as applicable, shall be tolled until such breach or violation has been duly cured. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Executive</U><U>&#146;</U><U>s Representations</U>. Executive hereby represents and warrants to the Company that (a)&nbsp;the execution,
delivery and performance of this Agreement by Executive do not and shall not conflict with, breach, violate or cause a default under any contract, agreement, instrument, order, judgment or decree to which Executive is a party or by which she is
bound, (b)&nbsp;except as previously disclosed to the Company in writing (a copy of each such agreement having been provided to the Company prior to the date hereof or being publicly available on EDGAR as of the date hereof), Executive is not a
party to or bound by any employment agreement, noncompete agreement or confidentiality agreement with any other person or entity, (c)&nbsp;except as previously disclosed to the Company in writing, Executive took nothing with her which belonged to
any former employer when Executive left her prior position and Executive has nothing that contains any information which belongs to any former employer, in either case which would reasonably be likely to result in any liability to Acadia or any
Subsidiary, and (d)&nbsp;upon the execution and delivery of this Agreement by the Company, this Agreement shall be the valid and binding obligation of Executive, enforceable in accordance with its terms. Executive hereby acknowledges and represents
that she has either consulted with independent legal counsel regarding her rights and obligations under this Agreement or knowingly and voluntarily waived the opportunity to do so and that she fully understands the terms and conditions contained
herein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Definitions</U>. For purposes of this Agreement, the following terms shall have the
meanings set forth below: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Cause</U>&#148; shall mean with respect to Executive one or more of the following: (i)&nbsp;the
conviction of or plea of nolo contendere to a felony or the conviction of any crime involving misappropriation, embezzlement or fraud with respect to Acadia or any of the Subsidiaries or any of their customers, suppliers or other business relations,
(ii)&nbsp;willful conduct outside the scope of Executive&#146;s duties and responsibilities under this Agreement that causes Acadia or any of the Subsidiaries substantial public disgrace or disrepute or demonstrable economic harm,
(iii)&nbsp;repeated failure to perform duties consistent with this Agreement as reasonably directed by the Board, which, for the avoidance of doubt, shall not include any failure by Executive to implement or achieve performance objectives relating
to the annual bonus plan or any performance-based restricted stock units; (iv)&nbsp;any willful act or knowing omission of aiding or abetting a competitor of Acadia or any of the Subsidiaries to the disadvantage or detriment of Acadia and the
Subsidiaries, (v)&nbsp;material breach of fiduciary duty or gross negligence, (vi)&nbsp;willful misconduct with respect to Acadia or any of the Subsidiaries, (vii)&nbsp;an administrative or other proceeding arising as a result of Executive&#146;s
action that results in the suspension or debarment of Executive from participation in any contracts with, or programs of, the United States or any of the fifty states or any agency or department thereof, or any finding of a governmental agency that
Executive personally has engaged in misconduct in connection with her employment by the Company, or (viii)&nbsp;any other material breach by Executive of this Agreement or any other agreement between Executive and Acadia or any of the Subsidiaries,
which, for the avoidance of doubt, shall not include any failure by Executive to implement or achieve performance objectives relating to the annual bonus plan or any performance-based restricted stock units, <U>provided</U> that no determination of
&#147;Cause&#148; may be made with respect to conduct described in prongs (ii), (iii), (v) or (viii)&nbsp;until Executive has been given written notice detailing the specific Cause event and a period of thirty (30)&nbsp;days following receipt of
such notice to cure such event; provided that there shall be no opportunity to cure a repeated violation of prong (iii). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Disabled</U>&#148; means any physical or mental disability or infirmity that has prevented the performance of Executive&#146;s duties
for a period of (i)&nbsp;one hundred twenty (120)&nbsp;consecutive days or (ii)&nbsp;one hundred eighty <FONT STYLE="white-space:nowrap">(180)&nbsp;non-consecutive</FONT> days during any twelve (12)&nbsp;month period. Any question as to the
existence, extent or potentiality of Executive&#146;s Disability upon which Executive and the Company cannot agree shall be determined by a qualified, independent physician selected by the Company and reasonably approved by Executive (or her
representative). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Good Reason</U>&#148; shall mean if Executive resigns her employment with the Company as a result of one or
more of the following actions (in each case taken without Executive&#146;s written consent): (i) a reduction in Executive&#146;s Base Salary; (ii)&nbsp;the assignment of job duties or responsibilities materially inconsistent with Executive&#146;s
position as a senior executive of the Company; (iii)&nbsp;any other material breach by the Company or Acadia (or their successors) of this Agreement (excluding any breach based on any diminution in Executive&#146;s duties, responsibilities, titles
or positions); or (iv)&nbsp;a relocation of the Company&#146;s and Acadia&#146;s principal executive offices and corporate headquarters outside of a thirty (30)&nbsp;mile radius of Nashville, Tennessee; provided that, none of the events described
above shall constitute Good Reason unless Executive shall have notified the Company and/or Acadia in writing describing the event which constitutes Good Reason within ninety (90)&nbsp;days after the occurrence of such event and then only if the
Company and/or Acadia and the Subsidiaries shall have failed to cure such event within thirty (30)&nbsp;days after the Company&#146;s and/or Acadia&#146;s receipt of such written notice and Executive elects to terminate her employment as a result at
the end of such thirty (30)&nbsp;day period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; shall mean an individual, a partnership, a corporation (whether or
not for profit), a limited liability company, an association, a joint stock company, a trust, a joint venture, or other business entity, an unincorporated organization and a governmental entity or any department, agency or political subdivision
thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsidiar</U>y&#148; shall mean any corporation or other entity of which the securities or other ownership interests
having the voting power to elect a majority of the board of directors or other governing body are, at the time of determination, owned by Acadia or of which Acadia serves as the managing member or in a similar capacity or of which Acadia holds a
majority of the partnership or limited liability company or similar interests or is otherwise entitled to receive a majority of distributions made by it, in each case directly or through one or more Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Survival</U>. <U>Sections 4</U> through <U>27</U> (other than <U>Section</U><U></U><U>&nbsp;22</U>) shall survive and continue in full
force in accordance with their terms notwithstanding the expiration or termination of the Employment Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Notices</U>. Any
notice provided for in this Agreement shall be in writing and shall be personally delivered, sent by email or facsimile (with hard copy to follow), sent by reputable overnight courier service, or mailed by first class mail, return receipt requested,
to the recipient at the address below indicated: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Notices to Executive: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Debra K. Osteen </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">[REDACTED] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">with copies (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Acadia Healthcare Company, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">6100 Tower Circle, Suite 1000 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Franklin, TN 37067 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attention:
General Counsel </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Facsimile: (615) <FONT STYLE="white-space:nowrap">261-9685</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Adam Kaminsky </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Davis
Polk&nbsp;&amp; Wardwell LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">901 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Street NW </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Washington, DC 2005 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Adam.kaminsky@davispolk.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Notices to the Company: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Acadia Healthcare Company, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">6100 Tower Circle, Suite 1000 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Franklin, TN 37067 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attention:
Board of Directors </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Facsimile: (615) <FONT STYLE="white-space:nowrap">261-9685</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">with copies (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Acadia Healthcare Company, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">6100 Tower Circle, Suite 1000 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Franklin, TN 37067 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attention:
General Counsel </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Facsimile: (615) <FONT STYLE="white-space:nowrap">261-9685</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or such other address or to the attention of such other Person as the recipient party shall have specified by prior written notice to the sending party. Any
notice under this Agreement shall be deemed to have been given when so delivered or sent by facsimile (subject to automatic proof of transmission) or email, one day after being sent by overnight courier or three days after being mailed by first
class mail, return receipt requested, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Severabilit</U>y. Whenever possible, each provision of this Agreement shall
be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such
invalidity, illegality or unenforceability shall not affect any other provision of this Agreement or any action in any other jurisdiction, but this Agreement shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal
or unenforceable provision had never been contained herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>Complete A</U>g<U>reement</U>. This Agreement and those documents
expressly referred to herein embody the complete agreement and understanding among the parties with respect to, and supersede and preempt any prior understandings, agreements or representations by or among the parties, written or oral, which may
have related to, the subject matter hereof in any way, including, without limitation, the Original Employment Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>No Strict
Construction</U>. The language used in this Agreement shall be deemed to be the language chosen by the parties hereto to express their mutual intent, and no rule of strict construction shall be applied against any party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>Counterparts</U>. This Agreement may be executed in separate counterparts (including by means of facsimile or by electronic
transmission in portable document format (pdf) or comparable electronic transmission), each of which is deemed to be an original and all of which taken together constitute one and the same agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <U>Successors and Assigns</U>. This Agreement is personal in nature and neither of the parties hereto shall, without the consent of the
other, assign, transfer or delegate this Agreement or any rights or obligations hereunder; provided that (i)&nbsp;this Agreement will inure to the benefit of and be enforceable by Executive&#146;s personal or legal representatives, executors,
administrators, successors, heirs, distributees and legatees (but otherwise will not otherwise be assignable, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
transferable or delegable by Executive), and (ii)&nbsp;this Agreement will be assignable, transferable or delegable by the Company, without the consent of Executive, to Acadia or any of the
Subsidiaries or to any successor (whether direct or indirect, in whatever form of transaction) to all or substantially all of the business or assets of the Company or Acadia or the Subsidiaries (none of which shall constitute a termination of
Executive&#146;s employment hereunder). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <U>Choice of Law and Forum</U>. All issues and questions concerning the construction,
validity, enforcement and interpretation of this Agreement and the exhibits and schedules hereto shall be governed by, and construed in accordance with, the laws of the State of Delaware, without giving effect to any choice of law or conflict of law
rules or provisions (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware. The parties agree that any dispute arising out of or relating to this
Agreement, exclusively shall be brought in the state courts located in Williamson County, Tennessee or the United States District Court for the Middle District of Tennessee. Each party hereby waives any objection to the personal or subject matter
jurisdiction and venue of such courts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <U>Amendment and Waiver</U>. The provisions of this Agreement may be amended or waived only
with the prior written consent of the Company (as approved by the Board) and Executive, and no course of conduct or course of dealing or failure or delay by any party hereto in enforcing or exercising any of the provisions of this Agreement
(including, without limitation, the Company&#146;s right to terminate the Employment Period for Cause) shall affect the validity, binding effect or enforceability of this Agreement or be deemed to be an implied waiver of any provision of this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. <U>Insurance</U>. The Company may, at its discretion, apply for and procure in its own name and for its own benefit life
and/or disability insurance on Executive in any amount or amounts considered advisable. Executive agrees to cooperate in any medical or other examination, supply any information and execute and deliver any applications or other instruments in
writing as may be reasonably necessary to obtain and constitute such insurance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20. <U>Indemnification and Reimbursement of Payments on
Behalf of Executive</U>. Acadia and the Subsidiaries shall be entitled to deduct or withhold from any amounts owing from Acadia or any of the Subsidiaries to Executive any federal, state, local or foreign withholding taxes, excise tax, or employment
taxes (&#147;<U>Taxes</U>&#148;) imposed with respect to Executive&#146;s compensation or other payments from Acadia or any of the Subsidiaries or Executive&#146;s ownership interest in Acadia or any of the Subsidiaries (including, without
limitation, wages, bonuses, dividends, the receipt or exercise of equity options and/or the receipt or vesting of restricted equity), as may be required to be deducted or withheld by any applicable law or regulation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21. <U>Waiver of Jury Trial</U>. AS A SPECIFICALLY BARGAINED FOR INDUCEMENT FOR EACH OF THE PARTIES HERETO TO ENTER INTO THIS AGREEMENT (AFTER
HAVING THE OPPORTUNITY TO CONSULT WITH COUNSEL), EACH PARTY HERETO EXPRESSLY WAIVES THE RIGHT TO TRIAL BY JURY IN ANY LAWSUIT OR PROCEEDING RELATING TO OR ARISING IN ANY WAY FROM THIS AGREEMENT OR THE MATTERS CONTEMPLATED HEREBY. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22. <U>Opportunity</U>. During the Employment Period, Executive shall submit to the Board
all material investment or business opportunities of which she becomes aware that would customarily be brought to the attention of a board of directors and which are within the scope and investment objectives of Acadia or any of the Subsidiaries.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23. <U>Executive</U><U>&#146;</U><U>s Cooperation</U>. During the Employment Period and thereafter, Executive shall cooperate with Acadia
and the Subsidiaries in any internal investigation or administrative, regulatory or judicial investigation or proceeding or any dispute with any third party as reasonably requested by Acadia or the Subsidiaries (including, without limitation,
Executive being available to Acadia and the Subsidiaries upon reasonable notice for interviews and factual investigations, appearing at Acadia&#146;s or any of the Subsidiaries&#146; request to give testimony without requiring service of a subpoena
or other legal process, volunteering Acadia and the Subsidiaries all pertinent information and turning over to Acadia and the Subsidiaries all relevant documents which are or may come into Executive&#146;s possession, all at times and on schedules
that are reasonably consistent with Executive&#146;s other permitted activities and commitments), all at Acadia&#146;s or the Subsidiaries&#146; sole cost and expense. Any services requested by the Company under this Section&nbsp;23 shall be
scheduled to not unreasonably interfere with Executive&#146;s employment or personal obligations at the time. It is expressly agreed that the Company&#146;s rights to avail itself of the advice and consultation services of Executive shall at all
times be exercised in a reasonable manner, that adequate notice shall be given to Executive in such events, and that <FONT STYLE="white-space:nowrap">non-compliance</FONT> with any such request by Executive for good reason, including, but not
limited to, ill health or prior commitments, shall not constitute a breach or violation of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">24. <U>Delivery by Facsimile
or PDF</U>. This Agreement, the agreements referred to herein, and each other agreement or instrument entered into in connection herewith or therewith or contemplated hereby or thereby, and any amendments hereto or thereto, to the extent signed and
delivered by means of a facsimile machine or electronic transmission in pdf, shall be treated in all manner and respects as an original agreement or instrument and shall be considered to have the same binding legal effect as if it were the original
signed version thereof delivered in person. At the request of any party hereto or to any such agreement or instrument, each other party hereto or thereto shall <FONT STYLE="white-space:nowrap">re-execute</FONT> original forms thereof and deliver
them to all other parties. No party hereto or to any such agreement or instrument shall raise the use of a facsimile machine or electronic transmission in pdf to deliver a signature or the fact that any signature or agreement or instrument was
transmitted or communicated through the use of a facsimile machine or electronic transmission in pdf as a defense to the formation or enforceability of a contract and each such party forever waives any such defense. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">25. <U>Indemnification and Directors and Officers Insurance</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) During the Employment Period and for a period of six (6)&nbsp;years thereafter, the Company shall, to the fullest extent permitted under
applicable law, indemnify and hold harmless Executive on a basis no less favorable than members of the Board and in accordance with the bylaws of the Company and Acadia. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) During the Employment Period and for a period of six (6)&nbsp;years thereafter, the Company, or any successor to the Company, shall
purchase and maintain, at its own expense, directors and officers liability insurance providing coverage for Executive in the same or greater amount as for members of the Board. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">26. <U>Legal Fees and Expenses</U>. In the event any litigation or other court action,
arbitration or similar adjudicatory proceeding (a &#147;<U>Proceedin</U>g&#148;) is commenced or threatened by any party hereto (the &#147;<U>Claiming Part</U>y&#148;) to enforce its rights under this Agreement against any other party hereto (the
&#147;<U>Defending Part</U>y&#148;), if the Defending Party is the prevailing party in such Proceeding, all fees, costs and expenses, including, without limitation, reasonable attorneys fees and court costs, incurred by the Defending Party in such
Proceeding, will be reimbursed by the Claiming Party, and, if the Claiming Party is the prevailing party in such Proceeding, all fees, costs and expenses, including, without limitation, reasonable attorneys fees and court costs, incurred by the
Claiming Party in such Proceeding, will be reimbursed by the Defending Party; provided that if the Defending Party prevails in part, and loses in part, in such Proceeding, the court, arbitrator or other adjudicator presiding over such Proceeding
shall award a reimbursement of the fees, costs and expenses incurred by the Claiming Party and the Defending Party on an equitable basis. For purposes of this <U>Section26</U>, and without limiting the generality of the foregoing, the Defending
Party will be deemed to have prevailed in any Proceeding if the Claiming Party commences or threatens such Proceeding and (i)&nbsp;the underlying claim(s) in such Proceeding are subsequently dropped or dismissed, or (ii)&nbsp;the Defending Party
defeats any such claim(s). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">27. <U>Acadia Guarantee</U>. Acadia unconditionally guarantees and promises to pay and perform, upon
Executive&#146;s demand following a default by the Company, any and all obligations of the Company from time to time owed to Executive under this Agreement, subject to any applicable cure period. Acadia further agrees that if the Company shall fail
to fulfill any of its obligations under this Agreement, Acadia will perform the same on demand as a principal obligor, and not as a surety. This is a continuing guarantee of the obligations and may not be revoked and shall not otherwise terminate
unless and until the obligations of the Company have been paid and performed in full. Acadia represents and warrants that it will receive a substantial benefit from Company&#146;s employment of Executive, which employment gives rise to the
obligations of the Company under this Agreement. Acadia acknowledges that Executive would not execute this Agreement if it did not receive this guarantee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">*&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp;&nbsp; * </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have executed this Employment Agreement as of the
date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">COMPANY:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ACADIA MANAGEMENT COMPANY, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Christopher L. Howard</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name: Christopher L. Howard</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Its: Vice President and Secretary</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">EXECUTIVE:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Debra K. Osteen</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Debra K. Osteen</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ACKNOWLEDGED AND AGREED:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ACADIA HEALTHCARE COMPANY, INC., solely with respect to Sections 7 and 27, as of this 19th day of January, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Christopher L. Howard</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name: Christopher L. Howard</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Its: Executive Vice President, Secretary and General Counsel</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Exhibit A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Other Activities </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Nashville Healthcare Council </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Exhibit B<SUP STYLE="font-size:85%; vertical-align:top">1</SUP> </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>GENERAL RELEASE </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I, <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, in
consideration of and subject to the performance by Acadia Management Company, Inc., a Delaware corporation (together with its subsidiaries, the &#147;<U>Company</U>&#148;), of its obligations under the Employment Agreement dated as of
January&nbsp;19, 2021 (the &#147;<U>Agreement</U>&#148;), do hereby release and forever discharge as of the date hereof the Company and its respective affiliates and all present, former and future managers, directors, officers, employees, successors
and assigns of the Company and its affiliates and direct or indirect owners (collectively, the &#147;<U>Released Parties</U>&#148;) to the extent provided below (this &#147;<U>General Release</U>&#148;). The Released Parties are intended to be
third-party beneficiaries of this General Release, and this General Release may be enforced by each of them in accordance with the terms hereof in respect of the rights granted to such Released Parties hereunder. Terms used herein but not otherwise
defined shall have the meanings given to them in the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. I understand that any payments or benefits paid or granted to me under
Section&nbsp;4 of the Agreement represent, in part, consideration for signing this General Release and are not salary, wages or benefits to which I was already entitled. I understand and agree that I will not receive certain of the payments and
benefits specified in Section&nbsp;4, unless I execute this General Release and do not revoke this General Release within the time period permitted hereafter. Such payments and benefits will not be considered compensation for purposes of any
employee benefit plan, program, policy or arrangement maintained or hereafter established by the Company or its affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. Except as
provided in paragraphs 5 and 6 below and except for the provisions of the Agreement which expressly survive the termination of my employment with the Company, I knowingly and voluntarily (for myself, my heirs, executors, administrators and assigns)
release and forever discharge the Company and the other Released Parties from any and all claims, suits, controversies, actions, causes of action, cross-claims, <FONT STYLE="white-space:nowrap">counter-claims,</FONT> demands, debts, compensatory
damages, liquidated damages, punitive or exemplary damages, other damages, claims for costs and attorneys&#146; fees, or liabilities of any nature whatsoever in law and in equity, both past and present (through the date that this General Release
becomes effective and enforceable) and whether known or unknown, suspected, or claimed against the Company or any of the Released Parties which I, my spouse, or any of my heirs, executors, administrators or assigns, may have, including those that
arise out of or are connected with my employment with, or my separation or termination from, the Company (including, but not limited to, any allegation, claim or violation, arising under: Title VII of the Civil Rights Act of 1964, as amended; the
Civil Rights Act of 1991; the Age Discrimination in Employment Act of 1967, as amended (including the Older Workers Benefit Protection Act); the Equal Pay Act of 1963, as amended; the Americans with Disabilities Act of 1990; the Family and Medical
Leave Act of 1993; the Worker Adjustment Retraining and Notification Act; the Employee Retirement Income Security Act of 1974; any applicable Executive Order Programs; the Fair Labor Standards Act; or their state or local counterparts; or under any
other federal, state or local civil or human rights law, or under any other </P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Note to Draft</U>: Subject to updates to the extent necessary for applicable governing law.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
local, state, or federal law, regulation or ordinance; or under any public policy, contract or tort, or under common law; or arising under any policies, practices or procedures of the Company; or
any claim for wrongful discharge, breach of contract, infliction of emotional distress, defamation; or any claim for costs, fees, or other expenses, including attorneys&#146; fees incurred in these matters) (all of the foregoing collectively
referred to herein as the &#147;<U>Claims</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. The released claims described in paragraph 2 hereof include all such claims,
whether known or unknown by me. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. I represent that I have made no assignment or transfer of any right, claim, demand, cause of action,
or other matter covered by paragraph 2 above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. I agree that this General Release does not waive or release any rights or claims that I
may have under the Age Discrimination in Employment Act of 1967 which arise after the date I execute this General Release. I acknowledge and agree that my separation from employment with the Company in compliance with the terms of the Agreement
shall not serve as the basis for any claim or action (including, without limitation, any claim under the Age Discrimination in Employment Act of 1967). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. I agree that I hereby waive all rights to sue or obtain equitable, remedial or punitive relief from any or all Released Parties of any kind
whatsoever in respect of any Claim, including, without limitation, reinstatement, back pay, front pay, and any form of injunctive relief. Notwithstanding the above, I further acknowledge that I am not waiving and am not being required to waive any
right that cannot be waived under law, including the right to file an administrative charge or participate in an administrative investigation or proceeding; <U>provided</U>, <U>however</U>, that I disclaim and waive any right to share or participate
in any monetary award resulting from the prosecution of such charge or investigation or proceeding. Additionally, I am not waiving (and nothing set forth herein shall be deemed a release of)&nbsp;(i) any right to any earned and accrued salary,
vacation, benefits, expense reimbursements, or any severance benefits to which I am entitled under the Agreement, (ii)&nbsp;any claim relating to directors&#146; and officers&#146; liability insurance coverage or any right of indemnification under
the Company&#146;s organizational documents, applicable law or otherwise, including, without limitation, Sections&nbsp;25 and 26 of the Agreement and/or (iii)&nbsp;my rights as an equity or security holder in the Company, Acadia or their affiliates.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. In signing this General Release, I acknowledge and intend that it shall be effective as a bar to each and every one of the Claims
hereinabove mentioned or implied. I expressly consent that this General Release shall be given full force and effect according to each and all of its express terms and provisions, including those relating to unknown and unsuspected Claims
(notwithstanding any state or local statute that expressly limits the effectiveness of a general release of unknown, unsuspected and unanticipated Claims), if any, as well as those relating to any other Claims hereinabove mentioned or implied. I
acknowledge and agree that this waiver is an essential and material term of this General Release and that without such waiver the Company would not have agreed to the terms of the Agreement. I further agree that in the event I should bring a Claim
seeking damages against the Company, or in the event I should seek to recover against the Company in any Claim brought by a governmental agency on my behalf, this General Release shall serve as a complete defense to such Claims to the maximum extent
permitted by law. I further agree that I am not aware of any pending claim of the type described in paragraph&nbsp;2 above as of the execution of this General Release. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. I agree that neither this General Release, nor the furnishing of the consideration for
this General Release, shall be deemed or construed at any time to be an admission by the Company, any Released Party or myself of any improper or unlawful conduct. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. I agree that if I violate this General Release by suing the Company or the other Released Parties, I will pay all costs and expenses of
defending against the suit incurred by the Released Parties, including reasonable attorneys&#146; fees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. Any <FONT
STYLE="white-space:nowrap">non-disclosure</FONT> provision in this General Release does not prohibit or restrict me (or my attorney) from responding to any inquiry about this General Release or its underlying facts and circumstances by the
Securities and Exchange Commission (SEC), the Financial Industry Regulatory Authority (FINRA), any other <FONT STYLE="white-space:nowrap">self-regulatory</FONT> organization or any governmental entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. I hereby acknowledge that Sections 4 through 27 (other than Section&nbsp;22) of the Agreement shall survive my execution of this General
Release. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. I represent that I am not aware of any claim by me other than the claims that are released by this General Release. I
acknowledge that I may hereafter discover claims or facts in addition to or different than those which I now know or believe to exist with respect to the subject matter of the release set forth in paragraph 2 above and which, if known or suspected
at the time of entering into this General Release, may have materially affected this General Release and my decision to enter into it. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. Notwithstanding anything in this General Release to the contrary, this General Release shall not relinquish, diminish, or in any way
affect any rights or claims arising out of any breach by the Company or by any Released Party of the Agreement after the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.
Whenever possible, each provision of this General Release shall be interpreted in, such manner as to be effective and valid under applicable law, but if any provision of this General Release is held to be invalid, illegal or unenforceable in any
respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision or any other jurisdiction, but this General Release shall be reformed, construed and enforced in such
jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BY SIGNING THIS GENERAL RELEASE, I REPRESENT AND
AGREE THAT: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I HAVE READ IT CAREFULLY; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I UNDERSTAND ALL OF ITS TERMS AND KNOW THAT I AM GIVING UP IMPORTANT RIGHTS, INCLUDING BUT NOT LIMITED TO,
RIGHTS UNDER THE AGE DISCRIMINATION IN EMPLOYMENT ACT OF 1967, AS AMENDED; TITLE VII OF THE CIVIL RIGHTS ACT OF 1964, AS AMENDED; THE EQUAL PAY ACT OF 1963; THE AMERICANS WITH DISABILITIES ACT OF 1990; AND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT
OF 1974, AS AMENDED; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I VOLUNTARILY CONSENT TO EVERYTHING IN IT; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I HAVE BEEN ADVISED TO CONSULT WITH AN ATTORNEY BEFORE EXECUTING IT AND I HAVE DONE SO OR, AFTER CAREFUL
READING AND CONSIDERATION, I HAVE CHOSEN NOT TO DO SO OF MY OWN VOLITION; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I HAVE HAD AT LEAST <B>[21][45]</B> DAYS FROM THE DATE OF MY RECEIPT OF THIS RELEASE TO CONSIDER IT, AND THE
CHANGES MADE SINCE MY RECEIPT OF THIS RELEASE ARE NOT MATERIAL OR WERE MADE AT MY REQUEST AND WILL NOT RESTART THE REQUIRED <B>[21][45]</B><FONT STYLE="white-space:nowrap">-DAY</FONT> PERIOD; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I UNDERSTAND THAT I HAVE SEVEN (7)&nbsp;DAYS AFTER THE EXECUTION OF THIS RELEASE TO REVOKE IT AND THAT THIS
RELEASE SHALL NOT BECOME EFFECTIVE OR ENFORCEABLE UNTIL THE REVOCATION PERIOD HAS EXPIRED; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I HAVE SIGNED THIS GENERAL RELEASE KNOWINGLY AND VOLUNTARILY AND WITH THE ADVICE OF ANY COUNSEL RETAINED TO
ADVISE ME WITH RESPECT TO IT; AND </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I AGREE THAT THE PROVISIONS OF THIS GENERAL RELEASE MAY NOT BE AMENDED, WAIVED, CHANGED OR MODIFIED EXCEPT BY
AN INSTRUMENT IN WRITING SIGNED BY AN AUTHORIZED REPRESENTATIVE OF THE COMPANY AND BY ME. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SIGNED:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">DATED:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>achc-20210119.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-7 Build:20201110.1 -->
<!-- Creation date: 1/22/2021 6:48:10 AM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2019-01-31"
  xmlns:achc="http://www.acadiahealthcare.com/20210119"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.acadiahealthcare.com/20210119"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="achc-20210119_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="achc-20210119_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>achc-20210119_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-7 Build:20201110.1 -->
<!-- Creation date: 1/22/2021 6:48:10 AM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>achc-20210119_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-7 Build:20201110.1 -->
<!-- Creation date: 1/22/2021 6:48:10 AM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="achc-20210119.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>d115514d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="achc-20210119.xsd" xlink:type="simple"/>
    <context id="duration_2021-01-19_to_2021-01-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
        </entity>
        <period>
            <startDate>2021-01-19</startDate>
            <endDate>2021-01-19</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2021-01-19_to_2021-01-19">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2021-01-19_to_2021-01-19"
      id="Hidden_dei_EntityCentralIndexKey">0001520697</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2021-01-19_to_2021-01-19">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2021-01-19_to_2021-01-19">2021-01-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2021-01-19_to_2021-01-19">Acadia Healthcare Company, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2021-01-19_to_2021-01-19">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2021-01-19_to_2021-01-19">001-35331</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2021-01-19_to_2021-01-19">45-2492228</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2021-01-19_to_2021-01-19">6100 Tower Circle</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2021-01-19_to_2021-01-19">Suite 1000</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2021-01-19_to_2021-01-19">Franklin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2021-01-19_to_2021-01-19">TN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2021-01-19_to_2021-01-19">37067</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2021-01-19_to_2021-01-19">(615)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2021-01-19_to_2021-01-19">861-6000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2021-01-19_to_2021-01-19">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2021-01-19_to_2021-01-19">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2021-01-19_to_2021-01-19">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2021-01-19_to_2021-01-19">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2021-01-19_to_2021-01-19">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2021-01-19_to_2021-01-19">ACHC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2021-01-19_to_2021-01-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2021-01-19_to_2021-01-19">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139655825948344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 19, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001520697<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 19,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Acadia Healthcare Company, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">45-2492228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6100 Tower Circle<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 1000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Franklin<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">37067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(615)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">861-6000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ACHC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M[0#/5TJ98\,>C,O_:XS_ 5!+ P04    " #@IC52@ZFE ]0!   R!@  #0
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M$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ X*8U4@=!36*!    L0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M" #@IC52G0&L;.\    K @  $0              @ &O    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    " #@IC52F5R<(Q &  "<)P  $P
M    @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( ."F-5(N
M]H$;1P0  .,0   8              " @0X(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    " #@IC52@ZFE ]0!   R!@  #0
M    @ &+#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( ."F-5*7BKL<P
M !,"   +              "  8H.  !?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M ."F-5(<.&7J/P$  #P"   /              "  7,/  !X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    " #@IC52)!Z;HJT   #X 0  &@
M@ '?$   >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #@
MIC5299!YDAD!  #/ P  $P              @ '$$0  6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     "0 ) #X"   .$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d115514d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d115514d8k.htm">d115514d8k.htm</File>
    <File>achc-20210119.xsd</File>
    <File>achc-20210119_lab.xml</File>
    <File>achc-20210119_pre.xml</File>
    <File>d115514dex101.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d115514d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d115514d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "achc-20210119_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "achc-20210119_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "achc-20210119.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "achc",
   "nsuri": "http://www.acadiahealthcare.com/20210119",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d115514d8k.htm",
      "contextRef": "duration_2021-01-19_to_2021-01-19",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d115514d8k.htm",
      "contextRef": "duration_2021-01-19_to_2021-01-19",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.acadiahealthcare.com//20210119/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001193125-21-013858-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-21-013858-xbrl.zip
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M19E;#(>&NT_Q>7G4)\##Q'=Q)-%>%EKKTH.KCWLZ9Z[6:@:6?<=8CQ='[%M
M"407FDNOJ+8:8V*W Q._Z)>@1'W+ZHGNCNQ06 \%*V-VD$ BCA(-[5*(A*S*
M1=& X$GIX$F!"S(S&$,B.[ G )\H>2)(AN=U4G4RGQ!E=>K>:IP)EH0A#TPJ
M7@5;E9J8'1;  I$JH#7^'5,U,&B1MD!% -QKB_P!DTOY")2=F0G?W0IAGC!G
MK.8[T4W8BY(>P"&!LT$\4 .AA+@^Y0,L%R5=\&^GS6:=Y/F>F0>"11DSKT Z
M,9:$AA0"FXSZ*Q#]C=9BHMO5"EAQD+*00EN>3TV3G26C7K4P BE#BR,$14>T
M#,5V5C[TS,G4F%'@ 4X>&MZ;I]R-SH5IHPROXLMQ4J=IOJP5D$V UZ;9H4^U
M\K$+ \C(&N9FI4>\6&I&B('+Q@#?):C(&B5D5 0+]8$F0@:\CK86\(&Z$8[(
MX*%@T_!T@)$\2 (%[L2, 8 !D3PX+C 2::$QO7@+D@VHEH 4]F7HR"?;2"1X
M NGHS0)3J=@(0 CS\WA@MND<$?TF(J4!R]\E])M'?-2T9)ZF+20]=#[$*A2>
MQ8"^$3[D0'JMCSO@QP%OWH$50"[.-^RJ.(=B\@X<RJ)!-'9!LDE\DZPTOI69
M%I#JH6+P; TU9]Z)V<3'S&P+83:ZPZ":@$K321=]D0&F8!!"<0R$85\(P0S5
M055QT"@)CFU1N+UO,"$;P(^>3@RI%V<AKJT11IPT!9@"FC41BW1MHC67WYUY
M=(=(C%6I]KHBC<G"^%MERC,S*G9"_^(+@ZFT 5:BF.Q&"]/O=C"*V:J)1"LE
M:BL;>@4FNS=^DY%1)]K7!YO6A7&["3\P^]03"#Y$'J[D8?82028V401]JHFW
M,!E'#;S"SHBD[\M-Q%J_&W=Z&HR&71%JU\[H/9BWR]$*(QJ,*X<Y^#[O@"YP
M*B74VX [?2$B"9]M;X BN_ ,^C*H.'IL8=U;5JMR<ERJ.*\VJ?4I39KKJ[XF
MUX2<97E-+<\Q;;%.\W6R4VT%;M)OG'Q9S#'#"YN07"O@)ZW VPY/K%""AZ<$
MM@S/?O ,%I*G50KF%M3JF<;C_6<NF%NYV"UAR#G7%U?BNQ5JD$CRBP/F5QR*
M'5^X/[9>OV-Y^+0C2?GL0I0V*<):6&JQ4>W@UO&GI:>(TO(H[.&!1NK83$K\
M6!+F"/PLER5W6[%E#M8RS>#DH,@#HU6?^0TML\IU+MW0LWHJ=C&%-Y28GW_P
M'.?@P*EY[-ZI.*5^-,"2A-0O'CN8DZ<(-G[PM+,W]^0%W3VZ$+=_'3K6GI2,
M&.))<@4[)&U4/-1$?N<THB2/:04/*PV0=C;SUM9*C^!OUQ#/O@09JU[&(I>:
M6?PX/D37DOB7/DG?Z6N2;MJ?+QJWOURW;AZ(0E<Y6EV[Y";[_G)319-F;=2*
M]5GFD/%ZLOS&B_T1T<EFS]1@V==ZFQ0?)IM-=@8=P0[K4[^+X21.I(\);0<,
M-&,\3=73 :WZ0L+&O(>BS=?K*LYU#J>"@(/$MUO'77SX/69KS?C018WM@W8P
MX<G..@S/I/S7N1BSGEOWN)E3^[B_*+Q[P'E<=O+8;)RW&^1+J_'M]DNS<:U_
MPN6J<?&? FE?-$M+WA"UB@> DOJ0"Z#;9WV I^J[.]_"_/9!?=+3JCK)KPJ\
M1,Y;F]L^CNK/NMYZUSN6E!ZN:5/+JDR:?0GF4(28B?Y6(E_$4%>\//,=C]>C
MREX0JRX@W1O97LS,<\DVKF_[7^XR<H4E#9X^]0#_5;((CZ\QY?S9GN+C:_$5
M\U<-CD[+^O<M3_6O7Y[]/U!+ P04    " #@IC52X!R/.?%B  #US $ $0
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M\QQ85O19E3GRP7OOX]<DH<'#X[0$189]N/U5&^V)_"%I(<0:#-FAT76#K<O
M:D&#BH.@&>P\V*9;SQ^*F49Z0#3B"SCTD<!XIH[R7223Y#+"T#93$9VJ9T_^
M9GAOXSPXX,!J" QHE&)L!768BSR:.(&UJHQB <(N!>-GEZ,YM:EI\R2:TE':
M@X%4WO4/.-PIR@<\=? !G0$1^^&-A,I)&M$IQ[233$.3S/9H8=NM$W,1,SU*
MG:'X##HH0/R5:/>GY?AFIXF7&R>^F(@8\Z.).\&';$).51SK55I*!(&B8(-*
MY@A'$X2915,,BALB\BD'!42"5CFPJ"L89A)O!Z(?3J)RCCHA>4P,QZ#UFD5I
MU;1MUJ<X+:=9L,&X10>W8QW#D@\P%5#&A2_SJ16?HZD<0 E;7X1H34J56L=H
M,F[M*DT;[:-"W#6=@[.3T(D]!S$2+6+R3%A2A>V=BTZB.3+^M*J:RK7FN+64
M<5;%O''HK5A6NR\W?2]&:2]@QYFH,/DJ85^]%6N:9:2APA5>#<D)XG,?L2Z.
M6['SK1F)-U>[8E*[CG(3N'G0Q^AG+\,\7YR2>_PJT1LTW^10('>8\-&*R,'S
M@(*HJ7D,G14D>4II$GZ%^X&_ W-<.DH[\4#8F'F1#I&6*&P:H$.P&KBGAW6N
M*M%[(F@:&F4] !ME[0NS[!+TE )5PD#__<G.GC@ ,1\&XSBT(WP9;Z CZ>60
ME]$4)@YL$DZ,9F(T<RAZ3LF[3-,W9NUD*6:J';\WWLU64I8\0!I6 \E=.$E
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MTP0D5.2X"M2-;BP8^:0T;TKLNV##2!MR"$9RCGUVXL6PH;),L@AQE]@T8'=
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MCO"O?*!J>E[4C0Z5QU2[4M7CZRJ3UWH/.PJC@S#Q!;A9O)=NE<]:%<!=\=S
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MY/ 3?/FN__[H]?\/4$L! A0#%     @ X*8U4ER5X&AJ P  /@P  !$
M         ( !     &%C:&,M,C R,3 Q,3DN>'-D4$L! A0#%     @ X*8U
M4M3Q6F6#!@  24<  !4              ( !F0,  &%C:&,M,C R,3 Q,3E?
M;&%B+GAM;%!+ 0(4 Q0    ( ."F-5+HRIP6S 0  -\L   5
M  "  4\*  !A8VAC+3(P,C$P,3$Y7W!R92YX;6Q02P$"% ,4    " #@IC52
M;O1"0 H3  "E=@  #@              @ %.#P  9#$Q-34Q-&0X:RYH=&U0
M2P$"% ,4    " #@IC52X!R/.?%B  #US $ $0              @ &$(@
G9#$Q-34Q-&1E>#$P,2YH=&U02P4&      4 !0!  0  I(4

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
